Chunghwa Post Co., Ltd.:企業の戦略・SWOT・財務分析

◆英語タイトル:Chunghwa Post Co., Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3948
◆発行会社(調査会社):MarketLine
◆発行日:2019年12月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Chunghwa Post Co., Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Chunghwa Post Co., Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Chunghwa Post Co., Ltd. (Chunghwa Post), also known as Taiwan Post, is a provider of postal services in Taiwan. It offers mail services including collection, processing, transmission and delivery of mail. It also offers postage stamps; banking services such as postal savings; international and domestic remittances, time deposit services, ATM and debit cards and government bonds; and simple life insurance products such as endowment insurance, mortality insurance, health insurance and accident insurance. Apart from this, it focuses on philately and related merchandise, remittance services and management of postal assets. It primarily operates in Taiwan. Chunghwa Post is headquartered in Taipei, Taiwan.

Scope

- Detailed information on Chunghwa Post Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Chunghwa Post Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Chunghwa Post Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Chunghwa Post Co., Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Chunghwa Post Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Chunghwa Post Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Chunghwa Post Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Chunghwa Post Co., Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Chunghwa Post Co., Ltd.: Company Overview
Chunghwa Post Co., Ltd.: Overview and Key Facts
Chunghwa Post Co., Ltd.: Overview
Chunghwa Post Co., Ltd.: Key Facts
Chunghwa Post Co., Ltd.: Key Employees
Chunghwa Post Co., Ltd.: Key Employee Biographies
Chunghwa Post Co., Ltd.: Major Products and Services
Chunghwa Post Co., Ltd.: Company History
Chunghwa Post Co., Ltd.: Management Statement
Chunghwa Post Co., Ltd.: Locations and Subsidiaries
Chunghwa Post Co., Ltd.: Key Competitors
Chunghwa Post Co., Ltd.: Company Analysis
Chunghwa Post Co., Ltd.: Business Description
Chunghwa Post Co., Ltd.: SWOT Analysis
Chunghwa Post Co., Ltd.: SWOT Overview
Chunghwa Post Co., Ltd.: Strengths
Chunghwa Post Co., Ltd.: Weaknesses
Chunghwa Post Co., Ltd.: Opportunities
Chunghwa Post Co., Ltd.: Threats
Chunghwa Post Co., Ltd.: Recent Developments
Chunghwa Post Co., Ltd.: News and Events Summary
Chunghwa Post Co., Ltd.: Contracts
Chunghwa Post Co., Ltd.: Financial Deals
Chunghwa Post Co., Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Chunghwa Post Co., Ltd.: Key Facts
Table 2: Chunghwa Post Co., Ltd.: Key Employees
Table 3: Chunghwa Post Co., Ltd.: Company History
Table 4: Chunghwa Post Co., Ltd.: Locations and Subsidiaries
Table 5: Chunghwa Post Co., Ltd.: Key Competitors
Table 6: Chunghwa Post Co., Ltd.: News and Events Summary
Table 7: Chunghwa Post Co., Ltd.: Contracts
Table 8: Chunghwa Post Co., Ltd.: Financial Deals
Table 9: Chunghwa Post Co., Ltd.: Strategy and Operations

★海外企業調査レポート[Chunghwa Post Co., Ltd.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gebr. Heinemann SE & Co KG:企業の戦略・SWOT・財務分析
    Gebr. Heinemann SE & Co KG - Strategy, SWOT and Corporate Finance Report Summary Gebr. Heinemann SE & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sime Darby Berhad (SIME):企業の財務・戦略的SWOT分析
    Sime Darby Berhad (SIME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aeras Global TB Vaccine Foundation Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aeras Global TB Vaccine Foundation Inc (Aeras) is a nonprofit biotechnology organization that develops tuberculosis (TB) vaccines. The organization provides TB vaccine candidates, preclinical candidates and vaccine candidates. It offers services such as portfolio management, preclinical rese …
  • Neurodyn Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Neurodyn Life Sciences Inc (Neurodyn Life Sciences), formerly Neurodyn Inc is a provider of validation and development of bioactives for neuroprotection and early treatment of neurological diseases. The company's products include neuroprotectant, memogain, progranulin, and nerve pain treatme …
  • GFH Financial Group BSC (GFH):企業の財務・戦略的SWOT分析
    GFH Financial Group BSC (GFH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Evoke Pharma Inc (EVOK):製薬・医療:M&Aディール及び事業提携情報
    Summary Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases. The company offers Gimoti that provides predictable absorption and symptom relief during a flare regardless of gastric emptying delays and vomiting. It also offers solutions fo …
  • CareDx Inc (CDNA):企業の製品パイプライン分析
    Summary CareDx Inc (CareDx) formerly XDx Inc, is a molecular diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. The company offers products which include AlloMap, a noninvasive blood test used by clinicians to monitor and …
  • Foundation Medicine Inc (FMI):医療機器:M&Aディール及び事業提携情報
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd, is a molecular information products provider. The company provides molecular information and cancer research programs. It offers clinical products such as FoundationOne for solid tumors and FoundationOne …
  • Lenovo Group Limited:企業のM&A・事業提携・投資動向
    Lenovo Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lenovo Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • PT Bukit Uluwatu Villa Tbk:企業の戦略・SWOT・財務情報
    PT Bukit Uluwatu Villa Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bukit Uluwatu Villa Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • KBP Instrument Design Bureau:企業の戦略・SWOT・財務分析
    KBP Instrument Design Bureau - Strategy, SWOT and Corporate Finance Report Summary KBP Instrument Design Bureau - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sorgenia SpA:企業の戦略的SWOT分析
    Sorgenia SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Osprey Medical Inc (OSP):医療機器:M&Aディール及び事業提携情報
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …
  • Ecolab Inc.:企業の戦略・SWOT・財務分析
    Ecolab Inc. - Strategy, SWOT and Corporate Finance Report Summary Ecolab Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Syngen Biotech Co Ltd (8279):製薬・医療:M&Aディール及び事業提携情報
    Summary Syngen Biotech Co Ltd (Syngen) is a biotechnology company. The company manufactures and supplies active pharmaceutical ingredients (APIs), biology fermentation products, nutritional ingredients, nutraceutical ingredients, biology agriculture and aquaculture products, and functional food prod …
  • EBSCO Industries Inc:企業の戦略的SWOT分析
    EBSCO Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Isovolta AG:企業の戦略的SWOT分析
    Isovolta AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Dechra Pharmaceuticals Plc (DPH):企業の財務・戦略的SWOT分析
    Summary Dechra Pharmaceuticals Plc (Dechra) is a manufacturer and distributor of veterinary pharmaceutical products. The company's product portfolio includes vetoryl, felimazole, thyforon, malaseb, canaural, isaderm, cardisure, comfortan, libromide, somulose, vetoryl, rapidexon, octacillin, domidine …
  • OSRAM Licht AG:企業のM&A・事業提携・投資動向
    OSRAM Licht AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's OSRAM Licht AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆